EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Reliability of Automated Amyloid PET Quantification: Real-World Validation of Commercial Tools Against Centiloid Project Method

Yeon-Koo Kang iD, Jae Won Min, Soo Jin Kwon, Seunggyun Ha

Tomography · 30.07.2025 · 11 (8) · 86

DOI: 10.3390/tomography11080086 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Tomography, online erschienen am 30.07.2025. Verfasst von Yeon-Koo Kang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine, Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591,…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Cognitive Dysfunction, Dementia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the growing demand for amyloid PET quantification, practical challenges remain. As automated software platforms are increasingly adopted to address these limitations, we evaluated the reliability of commercial tools for Centiloid quantification against the original Centiloid Project method.

Methods

This retrospective study included 332 amyloid PET scans (165 [18F]Florbetaben; 167 [18F]Flutemetamol) performed for suspected mild cognitive impairments or dementia, paired with T1-weighted MRI within one year. Centiloid values were calculated using three automated software platforms, BTXBrain, MIMneuro, and SCALE PET, and compared with the original Centiloid method. The agreement was assessed using Pearson’s correlation coefficient, the intraclass correlation coefficient (ICC), a Passing–Bablok regression, and Bland–Altman plots. The concordance with the visual interpretation was evaluated using receiver operating characteristic (ROC) curves.

Results

BTXBrain (R = 0.993; ICC = 0.986) and SCALE PET (R = 0.992; ICC = 0.991) demonstrated an excellent correlation with the reference, while MIMneuro showed a slightly lower agreement (R = 0.974; ICC = 0.966). BTXBrain exhibited a proportional underestimation (slope = 0.872 [0.860–0.885]), MIMneuro showed a significant overestimation (slope = 1.053 [1.026–1.081]), and SCALE PET demonstrated a minimal bias (slope = 1.014 [0.999–1.029]). The bias pattern was particularly noted for FMM. All platforms maintained their trends for correlations and biases when focusing on subthreshold-to-low-positive ranges (0–50 Centiloid units). However, all platforms showed an excellent agreement with the visual interpretation (areas under ROC curves > 0.996 for all).

Conclusions

Three automated platforms demonstrated an acceptable reliability for Centiloid quantification, although software-specific biases were observed. These differences did not impair their feasibility in aiding the image interpretation, as supported by the concordance with visual readings. Nevertheless, users should recognize the platform-specific characteristics when applying diagnostic thresholds or interpreting longitudinal changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyCognitive DysfunctionDementiaHumansRetrospective StudiesMaleReproducibility of ResultsFemaleAgedAniline CompoundsMiddle AgedSoftwareRadiopharmaceuticalsStilbenesMagnetic Resonance ImagingBenzothiazolesAged, 80 and overBrain

Stichwörter der Autor:innen

Centiloidamyloid PETartificial intelligencedementia

Substanzen

Aniline CompoundsRadiopharmaceuticalsStilbenes4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbeneBenzothiazolesflutemetamol

Autor:innen und Institutionen

  • Division of Nuclear Medicine, Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Division of Nuclear Medicine, Department of Radiology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea.

ORCID-Profile: Yeon-Koo Kang

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Kang, Y. K., Min, J. W., Kwon, S. J., & Ha, S. (2025). Reliability of Automated Amyloid PET Quantification: Real-World Validation of Commercial Tools Against Centiloid Project Method. Tomography, 11(8), 86. https://doi.org/10.3390/tomography11080086

Vancouver

Kang YK, Min JW, Kwon SJ, Ha S. Reliability of Automated Amyloid PET Quantification: Real-World Validation of Commercial Tools Against Centiloid Project Method. Tomography. 2025;11(8):86. doi:10.3390/tomography11080086

BibTeX
@article{Kang2025,
  author = {Kang, Yeon-Koo and Min, Jae Won and Kwon, Soo Jin and Ha, Seunggyun},
  title = {Reliability of Automated Amyloid PET Quantification: Real-World Validation of Commercial Tools Against Centiloid Project Method},
  journal = {Tomography},
  year = {2025},
  volume = {11},
  number = {8},
  pages = {86},
  doi = {10.3390/tomography11080086}
}
Kostenlos starten →